Vir Biotechnology, Inc. ($VIR)
Filing Information
| Accession Number | 0001628280-26-011331 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 25, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
76,829
Total Value
$13,631.17
P&L
+inf% (+$692,220.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Accounting Officer | Common Stock | โ | Feb 22, 2026 | Grant/Award | 25,000 | $0.00 | $0.00 | 72,872 | Direct | โ | View Details | |
SVP, Chief Accounting Officer | Common Stock | โ | Feb 23, 2026 | Sale | 1,829 | $7.45 | $13,631.17 | 71,043 | Direct | โ | View Details | |
SVP, Chief Accounting Officer | Stock Option (Right to Buy) | Derivative | Feb 22, 2026 | Grant/Award | 50,000 | $0.00 | $0.00 | 50,000 | Direct | โ | View Details |